Motivation: Efficient and accurate ascertainment of copy number variations (CNVs) at the population level is essential to understand the evolutionary process and population genetics, and to apply CNVs in population-based genome-wide association studies for complex human diseases. We propose a novel Bayesian segmentation approach to identify CNVs in a defined population of any size. It is computationally efficient and provides statistical evidence for the detected CNVs through the Bayes factor. This approach has the unique feature of carrying out segmentation and assigning copy number status simultaneously-a desirable property that current segmentation methods do not share. Results: In comparisons with popular two-step segmentation methods for a single individual using benchmark simulation studies, we find the new approach to perform competitively with respect to false discovery rate and sensitivity in breakpoint detection. In a simulation study of multiple samples with recurrent copy numbers, the new approach outperforms two leading single sample methods. We further demonstrate the effectiveness of our approach in population-level analysis of previously published HapMap data. We also apply our approach in studying population genetics of CNVs. Availability: R programs are available at
INTRODUCTION
Copy number variations (CNVs), abundant in apparently healthy individuals, are DNA segments at least 1 kb in size, with duplications or deletions, when compared with a reference genome (Feuk et al., 2006) . This newly identified structural variation is beginning to impact many forms of genetic analysis. One important application of CNVs is in genome-wide association scans (GWAS). Because CNVs usually have low linkage disequilibrium with currently available single nucleotide polymorphisms (SNPs), they can serve in a complementary role to SNPs (Estivill and Armengol, 2007) , * To whom correspondence should be addressed.
the primary tool in current GWAS. Current SNP-based GWAS largely miss the contribution of CNVs to complex traits. It can be expected that there will be an increasing number of CNV-integrated GWAS in the near future. Since population-based designs are widely adopted in GWAS, ascertainment of CNVs at the population level will certainly be very useful. Another important application is in studies of population genetics of structural variation. Population genetics of genomic structural variation plays an essential role in our understanding of the variation in the human genome and its origins and influence on human evolution processes and complex diseases (Conrad and Hurles, 2007) . Population-level analysis can provide population-specific CNVs for the study of population differentiation and for further studies of recent positive selection and recent human adaption to environmental pressures. In these population-based studies, it is very important to accurately and efficiently ascertain recurrent CNVs that consistently occur with some frequency across individuals in the population. Recently, Redon et al. (2006) reported the first-generation map of human copy number variations using 270 HapMap samples, which provides an excellent source for population-level analysis of CNVs.
Methods to ascertain CNVs in healthy populations are still rapidly developing. Fiegler et al. (2006) developed CNVfinder, a thresholdbased algorithm, for calling CNVs in the Whole Genome TilePath (WGTP) platform (Redon et al., 2006) . Wang et al. (2007) and Collella et al. (2007) developed hidden Markov model (HMM)-based algorithms, PennCNV and QuantiCNV, specifically for the Illumina platform. The former can incorporate family information and the latter contains an extension to handle multiple individuals. wuHMM (Cahan et al., 2008) and BreakPtr (Korbel et al., 2007) are another two HMM-based algorithms especially developed for high-resolution oligonucleotide arrays. Korn et al. (2008) proposed Birdseye, another HMM-based approach, to detect CNVs in SNP genotyping arrays (McCarroll et al., 2008) . Marioni et al. (2008) demonstrated an approach that uses pedigree information to assess the performance of different CNV-detection methods.
Many statistical and computational methods have been proposed to identify breakpoints of copy number alterations (CNAs) in tumor cells within an individual sample. Since CNAs are usually identified using the same array technologies as for CNVs, statistical methods for CNAs can often be applied to detect CNVs. Lai et al. (2005) compared several methods, and Willenbrock and Fridlyand (2005) employed a more realistic simulation scheme to compare three popular two-step segmentation methods, CBS (Olshen et al., 2004) , GLAD (Hupe et al., 2004) and an HMM approach of Fridlyand et al. (2004) , referred to as the F-HMM hereafter. F-HMM is the pioneering application of HMM in detection of CNVs. These segmentation methods, however, require post-processing procedures, e.g. MergeLevel, to assign copy number status (Willenbrock and Fridlyand, 2005) , hence they do not provide statistical evidence for the detected segments directly.
Other existing Bayesian approaches for single sample include Daruwala et al. (2004) , Broet and Richardson (2006) and PiqueRegi et al. (2008) . The method of Daruwala et al. (2004) involves dynamic programming with quadratic time-complexity. Broet and Richardson (2006) adopted a Bayesian mixture model using Markov chain Monte Carlo (MCMC) for inference. This approach requires visual inspection of the convergence of MCMC and is difficult to automate for large datasets. The GADA of (Pique-Regi et al., 2008) is a leading single sample approach that has similar performance as CBS but with much improved computational speed.
Methods proposed to identify recurrent CNAs within a group of tumor samples in multi-experiments have potential applications in population-level analysis of CNVs. The CMAR method (Rouveirol et al., 2006) and STAC (Diskin et al., 2006) are essentially twostage approaches, i.e. they are applied to copy number calls from other methods such as CBS. Two-stage methods ignore variations in the original data and are subject to the performance of first-stage methods. The H-HMM method (Shah et al., 2007) is an extension of F-HMM to handle multiple samples, but contains a biologically irrelevant tuning parameter and allows only one level of copy number gain or loss. Recently, Beroukhim et al. (2007) proposed the method of Genomic Identification of Significant Targets in Cancer (GISTIC) and Klijn et al. (2008) proposed KC-SMART, a kernel regression method. Both methods model the peak regions in multiexperiments and use permutations to identify statistically significant regions. In order to account for different lengths in CNAs, GISTIC tests if a CNA is a focal or broad event; KC-SMART needs repeated running with different kernel widths to construct a scale space. Moreover, permutation-based methods can be very time consuming for high-resolution array platforms.
The purpose of this report is to present and evaluate a novel Bayesian segmentation method designed to identify CNVs in a defined set of individuals of any sample size, including a single individual as a special case. This approach is quite general and computationally efficient. It has a fast searching method of chromosome peeling and employs closed-form marginal likelihood and Bayes factors. In comparisons with popular segmentation methods for a single individual such as CBS previously evaluated in the benchmark simulation studies (Willenbrock and Fridlyand, 2005) , we find the proposed method to perform competitively with respect to false discovery rates (FDRs) and sensitivity. In a simulation study of multiple samples with recurrent copy numbers, the proposed method outperforms two leading single sample methods, CBS and GADA. In addition, the new approach can carry out segmentation and assignment of copy number status simultaneously-a desirable feature that currently available segmentation methods do not share. The Bayes factor also provides statistical evidence to rank detected segments for downstream analysis such as biological validation.
The new method avoids the drawbacks of the two-stage method by direct utilization of log 2 ratios and can automatically take into account the different lengths in CNAs in multi-experiments analysis through the Bayes factor. In the population-level analysis of HapMap data, CNVs identified using our approach are located within those high-frequency copy number variable regions (CNVRs) of Redon et al. (2006) . In addition, our approach is able to identify CNVs within some regions of complex-type CNVs, where Redon et al. (2006) had difficulties in assigning copy number status. We also demonstrate the effectiveness of our approach in the study of population genetics of CNVs.
METHOD
We give a high-level overview of our methodology and the main considerations, while leaving all details that do not affect the understanding of our overall strategy in the Supplementary Material.
Statistical model
Suppose there are N unrelated individuals with raw copy number measurements at J genomic locations. Let y ij denote the intensity ratio of individual i at genomic location j. Let I denote a collection of genomic locations in a chromosome; let I 1 ,I 2 ,...,I K denote regions with CNVs, or simply signal regions; and write I 0 ≡ I\ K k=1 I k for the collective region with no CNV, or simply the background region (Fig. 1) . Under the assumption that copy number measurements of different individuals at different genomic locations are independent conditional on the boundaries of I 1 ,I 2 ,...,I K , we write the joint density of the data as follows:
where k (k = 1,2,...,K) are (nuisance) parameters describing the distributions of y ij and the notation, j ∈ I k , represents the copy number 
Nuisance parameters
Notice that the parameters of interest are the locations of the segments (boundaries of CNVs), i.e. I k ,k = 0,1,...,K, and 0 , 1 ,..., K are nuisance parameters. We adopt a Bayesian framework to integrate out these nuisance parameters. That is, we put prior distributions π ( k |ψ k ) on k , for k = 0,1,2,...,K. Here, ψ k is a hyperparameter. Then, the marginal likelihood
However, jointly maximizing the marginal likelihood (2) over I 1 ,I 2 ,...,I K is a very difficult problem. Notice that K is also an unknown parameter. Direct search methods such as the simplex method necessarily lead to an expensive combinatorial optimization problem. Daruwala et al. (2004) implemented the standard dynamic programming approach to maximize a likelihood of similar kind with time complexity of O(n 2 ), where n is the number of probes on a chromosome. This is quite slow, especially for high-resolution array platforms.
Sequential segmentation and working model
In the sequential approach, CNV segments I 1 ,I 2 ,... are identified one at a time. Once a segment is identified, data belonging to that segment are removed and the process is repeated using the remaining data to search for the next segment. The iterative process is terminated when the average of the highest sample mean of candidate segments is less than a prescribed threshold. This threshold, which will be supplied by the user, can be easily determined based on the knowledge of array platform.
In order to implement this approach, at each step we need to have (i) a collection of candidate segments; and (ii) a criterion to evaluate these candidate segments. To generate the collection of candidate segments for (i), we use a search method of chromosome peeling based on the PRIM algorithm (Friedman and Fisher, 1999) . Using multiple samples simultaneously, the search method generates a sequence of nested candidate segments with the overall increasing sample average. It completes searching for candidate segments with the time complexity of O(n) (see Section 2.1 in the Supplementary Material). For (ii), some additional considerations are needed. Given a candidate segment for CNV,Ĩ m , the entire chromosome sequence is effectively partitioned into two complementary regions: J 1 ≡Ĩ m (signal), and J 0 ≡ I\Ĩ m (background). Based on this partition, the joint density of the data can be written as
which we shall refer to as our 'working model'. One can think of (3) as a special case of (1) where K = 1. A natural strategy would be to evaluateĨ m by the marginal likelihood associated with our 'working model' above, i.e.
ML(m)
Obviously, if the partition generated byĨ m is correct, then ML(m) will be high. Given that there are m = 1,2,...,M candidate segments, this suggests picking the segment with the highest ML score, i.e. 
ML(m).
Because we are taking a sequential approach and dealing with only one candidate segment at a time, it is generally impossible for any one candidate segment alone to generate a partition that is 100% correct, and directly maximizing (4) at each step over the sequence,Ĩ 1 ,...,Ĩ M , would be too greedy and easily trapped into local maxima. Consider, for example, the situation depicted in Figure 1 . The candidatẽ I 2 is a signal region, but this does not mean the complementary region I\Ĩ 2 is necessarily a background region-other signal regions may still exist. In this particular situation, the candidate segmentĨ 1 actually generates a slightly better partition of the chromosome in terms of marginal likelihood score, i.e.
ML(1) > ML(2).
Using marginal likelihood score will lead to the choiceĨ 1 instead ofĨ 2 . This indicates that greedily pursuing ML score alone may lead to improper segmentation.
Bayes factor
Based on such considerations, we introduce an additional criterion-the Bayes factor-and use it together with the marginal likelihood (4) to evaluate each candidate segment. Consider two competing hypotheses:
Then, given y ij and j ∈Ĩ m , we have
Bayes factor is defined as
We use twice the natural logarithm, 2ln(BF(m)), in our algorithm (see Section 2.6).
Consider again the illustration of Figure 1 . Overall,Ĩ 1 generates a better partition thanĨ 2 , the correct candidate segment, in terms of marginal likelihood score, but its Bayes factor will be lower than that ofĨ 2 , becausẽ I 2 is a pure signal region whereasĨ 1 contains a subsegment that should belong to the background. This promotes the idea to choose the candidate segment with higher Bayes factor value. This approach, however, is not entirely satisfactory. Because of the noise in the data,Ĩ 3 could be a more homogenous signal segment and have a higher Bayes factor value thanĨ 2 . On the other hand,Ĩ 2 has higher ML score thanĨ 3 , because it contains a longer signal segment thanĨ 3 .
To balance this subtle tradeoff, we use both criteria-(4) and (7)together. Instead of picking the segment with the highest ML score or the highest Bayes factor value from all candidates, we restrict ourselves to candidates whose Bayes factors exceed a certain threshold, and pick the one with the highest ML score from this restricted subset.
Multi-level priors
In this section, we specify the hyperparameters ψ 0 and ψ 1 . Since J 0 is treated as background, ψ 0 is relatively easy to specify-depending on the model f (·|ψ), ψ 0 can simply be chosen so that π ( |ψ 0 )d is the expected level for any normal segment. Setting ψ 1 to any one particular value, however, would be impractical, since there can be multiple levels of copy number measurements corresponding to different levels of underlying copy numbers. Therefore, we adopt a finite sequence of priors,
..,T correspond to different levels of possible copy number measurements. For each candidate segmentĨ m , these priors lead to a sequence of Bayes factors and ML scores, one for each t:
BF(m,t) and ML(m,t), t = 1,2,...,T .
For each t, we first choose the segment with the highest ML score, provided that its Bayes factor is over the desired threshold. We then pick the segment with the largest ML score over t = 1,2,...,T . Details of the algorithm for finding regions of copy number duplication are presented in Table 1 . To find regions with copy number deletion, the same algorithm can be used after multiplying all measurements y ij by −1.
Evidence scales for the Bayes factor
The Bayes factor summarizes the evidence provided by data in support of one hypothesis as opposed to another. We adopt twice the natural logarithm of the Bayes factor, a scale proposed by Kass and Raftery (1995) , which is on the same scale as the widely adopted deviance and likelihood ratio test statistics. Under this scale, the segmentĨ m provides no evidence in favor of alternative hypothesis H t (signal) against the null hypothesis H 0 (background), if 2ln(BF(m,t)) is less than 2 (α 0 ); positive evidence if greater than 2 (α 1 ); strong evidence if greater than 6 (α 2 ) and very strong evidence if greater than 10 (α 3 ). In this study, we report relevant segments whose Bayes factors are at least 6.
The adaptive nature of the peeling algorithm may lead to identification of regions with high Bayes factors. When interpreting the evidence scale, users may choose to select a slightly higher evidence value than when evaluating hypotheses determined a priori.
A hierarchical Bayesian model
In previous sections, we present the general theory by adopting the generic densities f (y| ) for data and priors π ( |ψ t ). In this section, we specify a standard hierarchical Bayesian model for f (y| ) and conjugate priors π ( |ψ t ). Hierarchical modeling is a very practical tool and usually yields results that are reasonably robust to model misspecification.
First of all, we assume
That is, the nuisance parameter is simply (μ,σ 2 ). The prior distribution π ( |ψ t ) is specified as follows:
where 3. Specify a hierarchy of evidence scales, α 0 <α 1 <α 2 <α 3 . We take α 0 = 0, α 1 = 2,α 2 = 6,α 3 = 10 (see Section 2.6 ).
4. Specify a stopping threshold c. (11) and (12).
denote the maximum Bayes factor under the current prior ψ t . Let
be the highest evidence scale below the maximum Bayes factor attained by any candidate segment. From all segments whose Bayes factor exceeds α * t (the admissible subset), pick the one with largest ML score, that is,Ĩ k(t) , where
Record the highest admissible ML score under the current prior ψ t ,
s(t) = ML(k(t),t). End For.
3. (Select) Pick the segment with the largest ML score over the sequence of priors, t = 1,2,...,T , that isĨ k(t * ) , where
Until (Check stopping criterion)
whereȳ m is the sample mean of all y ij ∈Ĩ m .
To find deletion regions, the same algorithm can be applied after having multiplied all measurements by −1.
That is, π (μ|σ 2 ;ψ μ,t ) is a normal distribution with mean η t and variance σ 2 /a 0 ; and π (σ 2 |ψ σ ) is a scaled inverse-χ 2 distribution with hyperparameters ν and λ. Hence, the hyperparameter ψ consists of ψ μ,t ≡ (η t ,a 0 ) and ψ σ ≡ (ν,λ). We provide the detailed hyperparameter specifications in Section 1.3 of the Supplementary Material.
The hierarchical structure (8-10) is standard in the Bayesian literature. While this choice is convenient and practical, we emphasize again that our entire sequential segmentation algorithm (Table 1) can be, in theory, implemented with any other choices of f ( y| ) and π ( |ψ).
Closed-form formula for BF(m,t) and ML(m,t)
The hierarchical model with conjugate priors (8-10) allows us to evaluate both the Bayes factor and the marginal likelihood analytically. Using the prior value of ψ ≡ (η t ,a 0 ,ν,λ), the Bayes factor formula for candidate segment
where η 0 (η t ) is the specified hyperparameter for the expected log 2 ratio of background (signal) region;ȳ m is the sample mean; n m is the total observations in segmentĨ m , possibly from all locations withinĨ m and from all samples; s m is n m −1 times the sample variance of the candidateĨ m .
Notice that BF(m,t) is a function ofȳ m ,s m and n m . For candidate segments with the same s m and n m , the Bayes factor favors the segment with sample meanȳ m close to η t . Similarly, the Bayes factor favors segments with longer length (more observations, i.e. bigger n m ) or smaller sample variance when the other two quantities are fixed. Therefore, the candidateĨ m with the highest Bayes factor value is the one with the three quantities reaching a good balance. On the other hand, ifỹ m is close to η 0 , BF(m,t) will be small, i.e. in support of the null hypothesis of background. In summary, this Bayes factor penalizes sample variation s m and favors segment with sample mean y m that is close to η t and with more observations. Therefore, it automatically considers the lengths of candidate segments, while taking into account the sample mean and sample variance at the same time. This desirable property makes the new approach suitable for detecting CNVs with different lengths. We use 2ln(BF(m,t)) in our algorithm.
Because there is noise in data and the Bayes factor penalizes sample variation, the candidate segment with the highest Bayes factor may not be the optimal segment and can be slightly shorter than the true underlying segment. Therefore, we use the marginal likelihood to investigate if an expansion around the chosen segment is possible (See Fig. 1 for more illustration) . Such an expansion, if possible, will happen in a restricted set defined by the evidence scale of the highest Bayes factor value. The formula (based on the working model) is as follows,
where n m and n b are number of observations in candidate segmentsĨ m and background I \Ĩ m , respectively; s m is n m −1 times the sample variance ofĨ m ; s b is n b −1 times the sample variance of I \Ĩ m .
RESULTS AND DISCUSSION

Simulation studies
3.1.1 Single sample case We adopted the benchmark simulation studies (Willenbrock and Fridlyand, 2005) to compare our approach with the established two-step segmentation methods of CBS, GLAD and F-HMM. These approaches can output estimated breakpoints (boundaries of CNVs), but rely on post-processing procedures, such as MergeLevel (Willenbrock and Fridlyand, 2005) , to assign copy number status (gain or loss). Although our approach focuses on segmentation directly and provides statistical evidence for detected segments, breakpoints can be derived once segments are determined. By setting N = 1, our approach is applicable in this case. This dataset consists of 500 samples each with 20 chromosomes and 100 clones in each chromosome. The continuous log 2 ratios are increasingly ordered and assigned into one of six intervals corresponding to: one level of normal copy number, two levels of deletion and three levels of duplication. Gaussian noise was also added. The lengths of signal segments are sampled from the empirical distribution of a real breast cancer dataset. We assume that the prior information of expected values at signal levels is available as the middle point of the each interval for bounded intervals, and slightly beyond the endpoints for unbounded intervals. The stopping criterion, c, is set to be endpoint of the normal interval. In order to facilitate the comparison across different levels of signal/noise ratio, we selected segments that have ≥5 observations and 2ln(BF) ≥ 6.
The median FDR and median sensitivity at the each level of signal/noise ratio are presented in Tables 2 and 3. All breakpoints were evaluated within a one-clone error window. The FDR of breakpoint detection is the proportion of falsely predicted breakpoints among the predicted ones; sensitivity is the proportion of true breakpoints that were identified (Willenbrock and Fridlyand, 2005) . CBS has the best performance with the lowest FDR and the highest sensitivity in breakpoint detection. Our approach has the second best overall performance. F-HMM has similar overall sensitivity with our approach, but it has much higher FDR. In both categories, our approach outperforms GLAD.
We also defined the FDR for segmentation as the proportion of predicted segments that are completely outside the true signal segments. The results from the simulation study indicate that our Bayesian approach has low FDR for segmentation regardless of the signal/noise ratio-median FDR at the signal/noise ratio level of 1-2 is 0.07 and 0 at other levels of signal/noise ratios. That is, segments predicted from our approach usually contain at least part of the true segments. On the other hand, the Bayes factor prevents the predicted segments from containing too many non-signal genomic locations (see Section 2.4 and Fig. 1 ). This measurement is not available in the other three methods, because they do not output predicted segments directly.
Multiple samples with recurrent CNAs
The simulation scheme of Willenbrock and Fridlyand (2005) is modified to generate 100 samples, each with one chromosome and 200 clones. Three recurrent CNAs of different true copy numbers and lengths are placed on the chromosome. CNA 1 has 5 clones with copy number of 5; CNA 2 has 10 clones with copy number 4; and CNA 3 has 20 clones with copy number 3. We fix the lengths and locations of these CNAs, while retaining the feature of the original scheme that true log 2 ratio of each sample was generated by mixing of a random proportion of tumor cells and normal cells. Therefore, these samples can be considered as biological replications instead of technical replications (Yuk and Cavalieri, 2003) . Three levels of Gaussian noise are also added. First, the SD of the Gaussian noise for each sample is generated uniformly from (0.1, 0.2) [the default setting of Willenbrock and Fridlyand (2005) ]. Then, the SDs are generated uniformly from (0.2, 0.4) and (0.4, 0.6).
We apply the proposed Bayesian method and jointly analyze the 100 samples at the three noise levels. The prior values are chosen to be the expected log 2 ratios for each true copy number. The new method successfully identifies the exact CNA boundaries without error and reports no false positive findings. Table 4 presents the Bayes factor values [2ln(BF)] of the detected CNAs. Clearly, CNA 3 has the lowest Bayes factor value for a fixed noise level, due to the low signal/noise ratio; Bayes factor values decrease when the noise level increases, due to the increased variation in data.
We also apply two leading single sample methods, CBS and GADA, to each sample, and investigate their empirical power in identification of recurrent CNA boundaries at different noise levels. CBS has been shown in many simulation studies to perform consistently well and has become the benchmark method for comparison. GADA is a recent approach with similar performance as CBS and much improved computational speed. Other newly proposed methods, such as RJaCGH (Rueda and Diaz-Uriarte, 2007) and RHMM (Shah et al., 2006) , also have similar performance as CBS but with much longer computational time (Pique-Regi et al., 2008) and are not considered in this simulation study.
CBS and GADA are evaluated using their default program settings. Breakpoints are evaluated within a one-clone error window of the true boundaries. Since both approaches do not provide statistical evidence for segmentation directly, a log 2 ratio threshold of 0.2 is used. By adopting such a threshold, the false positive findings for both approaches are negligible. Table 5 presents the empirical power of CBS and GADA for breakpoint detection and segmentation at three noise levels. Generally, both methods have good power to detect the correct boundaries for the low noise level of (0.1, 0.2). However, their performance decreases sharply when noise level increases. Our Bayesian approach, on the other hand, identifies the exact true segments even when noise levels are high. Apparently, the proposed Bayesian approach outperforms CBS and GADA in terms of accuracy and power for both breakpoint detection and segmentation for recurrent CNAs using multiple samples. This is because the new approach, unlike single sample methods, uses the aggregate information from all samples and performs joint analysis. Figure 2 provides a further illustration. In plot (a), the signal regions of a randomly selected single sample are quite distinct from the background; whereas in (b) and (c) the signal regions of the sample become embedded in the background because of the increased noise level. Even the leading methods do not have high power in these cases. However, when we draw information from all samples, as in plot (d), the signal regions of 100 samples show elevated sample means from the background. Our Bayesian approach can utilize this fact to achieve high accuracy and power.
Sensitivity analysis for priors and stopping criterion
We use CNA 3 from the multiple-sample case with the highest noise level to carry out a sensitivity analysis for priors and stopping criterion. From the simulation model of Willenbrock and Fridlyand (2005) , the density function of true log 2 ratio x (before Gaussian noises is added) for copy number of three can be obtained as 5ln (2)2 x , and log 2 1.15 < x < log 2 1.35, whereas we adopt a normal distribution in our hierarchical Bayesian model. Clearly, this normal prior distribution is misspecified. The results of the simulation study, however, show that such a misspecification does not affect the ability of the proposed Bayesian approach to correctly identify CNA 3, provided that the hyperparameter η t , the expected log 2 ratio, is reasonably specified. We further vary η t by ±1 SD (obtained from the above distribution). In both cases, the proposed method correctly identify CNA 3 with Bayes factor values [2ln(BF)] of 11.13 for η t +1 SD and 10.44 for −1 SD. The fluctuation of Bayes factor values is small compared with the Bayes factor value of 11.22 when η t is used. Similar results can be expected if η t varies within this range. This sensitivity analysis indicates that the proposed Bayesian method is reasonably robust to prior misspecification and perturbations in the hyperparameter η t .
The specification of the stopping criterion can be conservative. The true log 2 ratio for copy number two is between −0.2 and 0.2 in the simulation study, and the stopping criterion of 0.15 for identification of duplications does not affect the performance of the algorithm. On the other hand, unreasonably high stopping criterion can make the algorithm stop early and may lead to false negative findings. Noise level: range of the SD of the Gaussian noise; Start (End): empirical power to detect the first (last) genomic location of the true CNAs, evaluated within a one-clone error window; S1,S2,S3: empirical power to detect the correct CNAs within a one-clone error window at each of the two boundaries. 
Population-level analysis of HapMap collection.
The first-generation human CNV map based on a survey of 270 Hapmap samples (Redon et al., 2006) provides a good source for population-level analysis of CNVs. We adopted the raw copy number log 2 ratio measurements of HapMap populations from the WGTP arrays (Redon et al., 2006) Redon et al. Redon et al. (2006) adopted CNVfinder (Fiegler et al., 2006 ) to identify respective individuallevel CNVs in WGTP platform. By merging overlapping individuallevel CNVs across individuals in the sample, they identified 913
Comparison with
CNVRs (Redon et al., 2006) . These CNVRs are often CNVscontaining regions and encompass multiple juxtaposed CNVs. Redon et al. (2006) further delineate these CNVRs into 1116 CNVs of five types, including a complex type for which they had difficulties in assigning copy number status. When individual-level CNVs of different types are merged to form a CNVR, it can be difficult to identify the type of the CNVs within the CNVR. Even when CNVRs are formed by merging individual-level CNVs of the same type, the boundaries of recurrent CNVs can be distorted and make it hard to find population-level CNVs using just those individual-level CNVs calls. We apply the proposed Bayesian approach to the log 2 ratios of HapMap samples and obtained genome-wide population-specific CNVs. We found 450 population-level CNVs in these four populations. After removing duplicated CNVs that appeared in multiple populations, we obtained 247 unique population-level CNVs. All detected CNVs but one are nested within or identical to CNVRs of Redon et al. (2006) . The one exception is likely a false positive finding. The 247 unique population-level CNVs have the average size of 219 kb (median size 176 kb), much shorter than the CNVRs with average size 350 kb (median size 228 kb). About 88% of 247 CNVs overlapped with the high-frequency CNVRs (20 individuals or more) (Redon et al., 2006) . This demonstrates that the population-level CNVs detected by our approach do locate in CNV-containing regions of Redon et al. (2006) .
When we compared our findings with CNVs previously identified, about 82% of CNVs identified by our approach are contained in, i.e. are shorter than, CNVs in Redon et al. (2006) . This implies that the CNVs from Redon et al. (2006) are often CNV-containing regions for the population-level CNVs. One reason is that the common regions where individual-level CNVs overlap could potentially contain population-level CNVs. This also indicates that CNVs from Redon et al. (2006) could not provide accurate identifications, especially the boundaries, of the population-level CNVs. More importantly, we found that 38% (94 out of 247) population-level CNVs are in the regions of complex-type CNVs, where Redon et al. (2006) had difficulties in assigning copy number status.
Comparison with McCarroll et al.
We also compare these population-level CNVs with a recent map of McCarroll et al. (2008) , which was constructed by using high-density SNP genotyping arrays on the same set of HapMap individuals. McCarroll et al. (2008) reported CNVs that were much smaller in size than those in Redon et al. (2006) . There are 87 of the 160 high-frequency CNVRs in Redon et al. (2006) that contain CNVs in McCarroll et al. (2008) . About half of these 87 CNVRs also contain population-level CNVs identified by our Bayesian approach and these CNVs contain smaller-sized CNVs of McCarroll et al. (2008) . This indicates that some population-level CNVs we identified may be even smaller in size, since almost all these CNVs are single clones, i.e. the highest resolution that can be achieved by the WGTP array. Thus, by drawing information from multiple HapMap samples, our approach can achieve higher accuracy than single sample method for identification of population-level CNVs.
Two regions in chromosome 4
We further illustrate the differences between our approach and Redon et al. (2006) by studying two regions in chromosome 4. One region is at 4p15.32. Redon et al. (2006) reported a CNVR ranging from 15 120 886 bp to 15 425 789 bp and subsequently classified it as a CNV of complex-type [WGTP event CNV_id: Chr4_13 in Supplementary  Table 11B of Redon et al. (2006) ], i.e. copy number status unknown. Our approach was able to find a common deletion ranging from 15 233 230 bp to 15 425 789 bp in all HapMap populations (Supplementary Table 1) . This population-level CNV is in the vicinity of CD38. Both CD157 and CD38 belong to the CD38 multifunctional ectoenzyme family. CD38 knockout mice exhibit impaired maternal nurturing in female and social behavior in male (Jin et al., 2007) . Jin et al. (2007) also hypothesized that mutations of human CD38 may be a disease-causing factor for autism.
Another region is at 4q33. Redon et al. (2006) found a CNVR ranging from 169 109 321 bp to 169 426 423 bp. This CNVR contains the gene annexin A10 [Supplementary Table 12 of Redon et al. (2006) ]. They reported a CNV with the same boundaries as a deletion (WGTP event CNV_id: Chr4_44 in Supplementary Table  11B of Redon et al. (2006) ]. In contrast, our approach detected three slightly different population-level duplications with strong statistical evidence in all HapMap populations (Supplementary Table 1 ). Our findings are consistent with a recent map of Perry et al. (2008) , constructed by using a high-resolution arraybased comparative genomic hybridization platform. A duplication ranging from 168 184 090 bp to 169 366 713 bp was detected in all 30 HapMap individuals they used [ Table S3 of Perry et al. (2008) ]. These CNVs contain the gene annexin A10, which is a member of a subfamily of vertebrate annexins and was found to play an important role in genome duplications during early chordate evolution (Morgan et al., 1999 ). These three high-level duplications with strong statistical evidence may indicate possible fixation of these population-level CNVs in humans before ethnic differentiation.
Genome-wide population-level CNVs
The frequency of genome-wide population-level CNVs of four HapMap populations is depicted in Supplementary Figure 2 . CEU has fewer CNVs compared with YRI, CHB and JPT. CHB and JPT have similar patterns of genome-wide CNVs distribution. We found that duplications account for 53% and deletions 47% of the 247 unique CNVs, and the difference between these two proportions is not statistically significant. This is consistent with the previous finding in Redon et al. (2006) . Moreover, we found that the number of population-level duplications and deletions are not equally distributed in human genome. In all HapMap populations, chromosomes 1 and 4 have more duplications than deletions; whereas chromosomes 2, 10, 19, 20, 22 have more deletions than duplications. We also found that 116 CNVs are present in multiple populations, which may imply that some CNVs are evolutionarily ancient and occurred prior to the human population differentiation, as hypothesized by Sharp et al. (2005) .
3.2.5
The 'waves' in the WGTP data (Marioni et al., 2007) reported a wave artifact that consistently appears across the HapMap samples in the WGTP data. This artifact, caused by the spatial autocorrelation of clones, can add non-biological variability to the data and may lead to difficulties for statistical methods that use crosssample information. The wave effect prevented them from clustering the HapMap individuals into proper ethnic groups and can cause potential false positive findings when fitting mixture models. They also reported that there were almost no wave-induced false positive CNVRs in Redon et al. (2006) , as virtually all CNVRs (99.4%) identified by CNVfinder before wave correction were also flagged after wave correction. This indicates that the wave effect does not affect the performance of the new Bayesian approach to identify high-frequency recurrent CNVs in the HapMap samples, because our findings are in good agreement with that of Redon et al. (2006) . This also shows that our approach is robust to the wave effect in terms of wave-induced false positive findings. Moreover, the wave effect can be effectively reduced by smoothing methods such as loess for the large-insert bacterial artificial chromosome (BAC) arrays (Marioni et al., 2007) and fitting linear regression with local GC content as covariate for several high-density SNP genotyping arrays (Diskin et al., 2008) . These normalization practices can increase the signal/noise ratio in the wave-corrected data and potentially lead to more CNV findings.
Applications in population genetics
The population-specific CNVs identified by our approach can provide good candidates for further population genetics studies. We focus on chromosomes 4 and 17, mainly because Redon et al. (2006) focus on these two in presenting their population genetics results. Redon et al. (2006) adopted a clone-based approach and devised the statistic V st to identify population differentiation at each clone. In contrast, we use the population-level CNVs and the commonly used statistic F st .
Using the outliers of V st , they identified two clones with population differentiation suggestive of recent positive selection. One clone is on chromosome 4 (69 126 468-69 296 476 bp) and they found high population differentiation between YRI and CHB+JPT, the combined Asian population. Our approach shows this clone to be a population-level CNV for the CEU population, and finds a slightly longer CNV in the YRI population. However, no population-level CNV was detected in this region for CHB and JPT (Table 6 ). Another clone is on chromosome 17 (31 583 743-31 651 855 bp) where they found population differentiation between YRI and CEU. We find that YRI has a population-level duplication containing this clone, whereas CEU has no population-level CNVs in this region. JPT has a duplication at the same location with YRI, but with slightly lower log 2 ratios. CHB has a shorter population-level duplication in this region. Redon et al. (2006) also reported a clone (41 635 804-41 722 491 bp) on chromosome 17 that overlapped with regions (Table 6 ) and no duplications in this region in YRI, CHB and JPT. Apparently, the detected CNV is closer to MAPT and longer than the clone in Redon et al. (2006) . Our analysis indicates that CEU may have a duplication with partial selective sweep in a longer region that contains the clone reported in Redon et al. (2006) . In order to calculate F st for these CNVs, we applied our method to obtain individual-level CNVs (2ln(BF) > 6) in chromosomes 4 and 17. The genotypes of individuals with population-level duplications can be defined as NN, NP, PP, where N stands for copy number of two and P for duplication. A similar definition was adopted in Marioni et al. (2008) . The genotypes of NP and PP cannot be easily distinguished from the output of our method. By assuming Hardy-Weinberg equilibrium, the allele frequencies of N and P can be obtained through the genotype frequency of NN. The F st and its Bootstrap confidence interval are obtained according to Weir (1996) . The duplication frequencies (NP and PP) are presented in Supplementary Table 2; pairwise F st and 95% Bootstrap confidence intervals in Supplementary Table 3. For the duplication at chromosome 4, population differentiation between CEU and YRI is not statistically significant; while both CEU and YRI demonstrate statistically significant genetic divergence from CHB and JPT (Supplementary Table 3 ). The duplication at chromosome 17 (41 559 185-41 843 177 bp) is unique to CEU and with population frequency about 33% (Supplementary  Table 2 ). It is expected that the pairwise F st between CEU and other populations is statistically significant (Supplementary Table  3 ). The YRI population has the highest frequency about 55% for the duplication at chromosome 17 (31 401 905-31 981 395 bp); while CEU has the lowest population frequency at this duplication, about 3%. Pairwise F st indicates statistically significant genetic differentiation between YRI and other HapMap populations at this duplication. As expected, the genetic differentiation between CHB and JPT at these genomic locations, as reported in Supplementary  Table 3 , is either negligible or marginally significant.
DISCUSSION
In this study, we proposed a general Bayesian segmentation approach to ascertain population-level CNVs in a defined population of any size. This approach is computationally efficient and provides statistical evidence through Bayes factor to prioritize the detected CNVs for downstream analysis such as biological validation. In addition, our approach has the feature of integrating segmentation and assignment of copy number status. The simulation study of segmentation in single samples shows that the new approach has low FDR regardless of the level of signal/noise ratio. The Bayes factor can prevent the predicted segments from containing many nonsignal genomic locations. In comparison with popular single-sample approaches, the proposed approach performs well in breakpoint detection. In the simulation study datasets, detected segments separated by a single clone were combined occasionally. This practice is usually safe because of the low FDR for segmentation, so will not violate the selection criterion. Low sensitivity in breakpoint detection in comparison with CBS indicates that the proposed approach is conservative in single-sample analysis. This is likely due to the greediness of the chromosome peeling algorithm. We are currently working on ways to mitigate this greediness by allowing non-nested candidate segments in the restricted candidate subset. The simulation study of multiple samples with recurrent CNAs shows that our new approach outperforms the leading single sample approaches of CBS and GADA. Our population-level analysis of the HapMap data reproduces some of the high-frequency CNVs previously reported (Redon et al., 2006) . In addition, we found population-level CNVs inside some of the complex-type CNVs, where Redon et al. (2006) had difficulty in assigning copy number status. We also demonstrate the effectiveness of our approach in studying population genetics of CNVs. With the dramatic increase in copy number data, prior information for the effective application of this new Bayesian approach will be abundant.
This Bayesian approach can assign each individual a posterior probability to have a CNV at a given intensity level. Consider the m-th detected CNV, and let P(m i ,t) be the posterior probability for individual i to have a CNV at the t-th intensity level, then, P(m i ,t) = B(m i ,t)/ T t=0 B(m i ,t) for each t. Here, we assume equal prior probability for each intensity level and B(m i ,0) = 1. These posterior probabilities can be used in the subsequent genetic association studies to account for some uncertainty in CNV ascertainment. Based on these posterior probabilities and intensity level, we can calculate the expected intensity score; if a corresponding relationship between intensity levels and integer copy numbers can be established, then we calculate expected copy number. Either the expected intensity score or the expected copy number can be incorporated in genetic association studies. This expectation-substitution method, essentially a Bayesian model averaging approach, has been used to account for the uncertainty in ascertainment of unphased haplotype and shown to perform well in genetic association studies (Kraft et al., 2005) .
Our Bayesian approach also has potential applications in multiexperiments analysis in finding recurrent CNAs in tumor cells and in other array platforms such as high-density, high-resolution oligonucleotide arrays and SNP genotyping arrays. High-resolution arrays usually contain a high level of noise; the hierarchical Bayesian model in our approach allows extra variations in data and could be suitable for such arrays.
The population-level CNVs identified by our Bayesian approach are generally much shorter than these in Redon et al. (2006) . This is consistent with recent maps using high-resolution array platforms (McCarroll et al., 2008; Perry et al., 2008) . Perry et al. (2008) also reported that a small proportion of CNVs, about 8% of their detected CNVs, exhibit complex architecture including smaller CNVs contained within larger ones, CNVs with interindividual breakpoints variation or CNVs with juxtaposed duplications and deletions within the same individuals. Since these CNVs with complex architectures are of great individuality, joint analysis using all samples will not be effective, because the individuality will be lost when information from multiple samples is aggregated. Applications of single sample methods such as CBS or our Bayesian approach by setting the sample size equal to one may be helpful. These complexities in copy number data not only pose difficulties in data analysis, but also present new challenges and opportunities for the data analyst to develop new statistical methods.
